370 related articles for article (PubMed ID: 30958914)
1. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
2. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.
Jenkins DE; Oei Y; Hornig YS; Yu SF; Dusich J; Purchio T; Contag PR
Clin Exp Metastasis; 2003; 20(8):733-44. PubMed ID: 14713107
[TBL] [Abstract][Full Text] [Related]
3. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
Scatena CD; Hepner MA; Oei YA; Dusich JM; Yu SF; Purchio T; Contag PR; Jenkins DE
Prostate; 2004 May; 59(3):292-303. PubMed ID: 15042605
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging.
Thalheimer A; Korb D; Bönicke L; Wiegering A; Mühling B; Schneider M; Koch S; Riedel SS; Germer CT; Beilhack A; Brändlein S; Otto C
J Surg Res; 2013 Nov; 185(1):143-51. PubMed ID: 23998649
[TBL] [Abstract][Full Text] [Related]
5. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal measurement of subcutaneous and intratibial human prostate cancer xenograft growth and response to ionizing radiation by plasma Alu and LINE-1 ctDNA: A comparison to standard methods.
Mishra A; Zennami K; Velarde E; Thorek DLJ; Yegnasubramanian S; DeWeese TL; Lupold SE
Prostate; 2021 Aug; 81(11):745-753. PubMed ID: 34032307
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
[TBL] [Abstract][Full Text] [Related]
8. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
Huebner D; Rieger C; Bergmann R; Ullrich M; Meister S; Toma M; Wiedemuth R; Temme A; Novotny V; Wirth MP; Bachmann M; Pietzsch J; Fuessel S
BMC Cancer; 2017 Nov; 17(1):790. PubMed ID: 29169339
[TBL] [Abstract][Full Text] [Related]
9. Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models.
Zhang C; Yan Z; Arango ME; Painter CL; Anderes K
Clin Cancer Res; 2009 Jan; 15(1):238-46. PubMed ID: 19118051
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
11. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.
Saha D; Dunn H; Zhou H; Harada H; Hiraoka M; Mason RP; Zhao D
J Vis Exp; 2011 Oct; (56):. PubMed ID: 21989061
[TBL] [Abstract][Full Text] [Related]
12. Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis.
Black PC; Shetty A; Brown GA; Esparza-Coss E; Metwalli AR; Agarwal PK; McConkey DJ; Hazle JD; Dinney CP
BJU Int; 2010 Dec; 106(11):1799-804. PubMed ID: 20500508
[TBL] [Abstract][Full Text] [Related]
13. Quantitative bioluminescence imaging of mouse tumor models.
Tseng JC; Kung AL
Cold Spring Harb Protoc; 2015 Jan; 2015(1):pdb.prot078261. PubMed ID: 25561617
[TBL] [Abstract][Full Text] [Related]
14. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging.
Inoue Y; Kiryu S; Izawa K; Watanabe M; Tojo A; Ohtomo K
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):771-9. PubMed ID: 19096841
[TBL] [Abstract][Full Text] [Related]
15. Bioluminescent animal models of human breast cancer for tumor biomass evaluation and metastasis detection.
Shan L; Wang S; Korotcov A; Sridhar R; Wang PC
Ethn Dis; 2008; 18(2 Suppl 2):S2-65-9. PubMed ID: 18646323
[TBL] [Abstract][Full Text] [Related]
16. Recent achievements of bioluminescence imaging based on firefly luciferin-luciferase system.
Li S; Ruan Z; Zhang H; Xu H
Eur J Med Chem; 2021 Feb; 211():113111. PubMed ID: 33360804
[TBL] [Abstract][Full Text] [Related]
17. ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.
Zhang Y; Bressler JP; Neal J; Lal B; Bhang HE; Laterra J; Pomper MG
Cancer Res; 2007 Oct; 67(19):9389-97. PubMed ID: 17909048
[TBL] [Abstract][Full Text] [Related]
18. Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals.
Klerk CP; Overmeer RM; Niers TM; Versteeg HH; Richel DJ; Buckle T; Van Noorden CJ; van Tellingen O
Biotechniques; 2007 Jul; 43(1 Suppl):7-13, 30. PubMed ID: 17936938
[TBL] [Abstract][Full Text] [Related]
19. In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase.
Mezzanotte L; Fazzina R; Michelini E; Tonelli R; Pession A; Branchini B; Roda A
Mol Imaging Biol; 2010 Aug; 12(4):406-14. PubMed ID: 19937390
[TBL] [Abstract][Full Text] [Related]
20. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission.
Keyaerts M; Verschueren J; Bos TJ; Tchouate-Gainkam LO; Peleman C; Breckpot K; Vanhove C; Caveliers V; Bossuyt A; Lahoutte T
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):999-1007. PubMed ID: 18180921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
